Joseiz 50mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing. This mechanism contributes to its efficacy in reducing seizure frequency. Joseiz 50mg is typically administered orally and can be used as monotherapy or as adjunctive therapy in adults and pediatric patients aged four years and older. The dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize adverse effects. Common side effects include dizziness, headache, nausea, and fatigue, while serious adverse reactions may involve cardiac conduction abnormalities; therefore, caution is advised in patients with preexisting cardiac conditions. Regular monitoring and consultation with a healthcare professional are essential to ensure optimal therapeutic outcomes and safety. Joseiz 50mg should be used under strict medical supervision, with attention to potential drug interactions, particularly with other antiepileptic drugs. It is contraindicated in patients with known hypersensitivity to lacosamide or any excipients in the formulation. Pregnant or breastfeeding women should use this medication only if clearly needed and under medical advice.